Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 15, 2015

Primary Completion Date

May 15, 2018

Study Completion Date

December 15, 2018

Conditions
Papilloma Viral InfectionPapillomavirus InfectionsEsophageal Viral WartEsophageal Verrucous Carcinoma
Interventions
DIETARY_SUPPLEMENT

Viusid®

The VIUSID nutritional supplement is presented in the form of envelopes and will be administered orally diluted in water, juice or milk, according to the patient's preference and will be administered 3 times a day, 15 minutes before breakfast, lunch and dinner.

DIETARY_SUPPLEMENT

Glizigen®

The GLIZIGEN® product is presented in spray bottles and will be administered orally to swallow, away from meals 2 times a day.

DIETARY_SUPPLEMENT

Viusid Placebo

The placebo of VIUSID nutritional supplement is presented in the form of envelopes and will be administered orally diluted in water, juice or milk, according to the patient's preference and will be administered 3 times a day, 15 minutes before breakfast, lunch and dinner .

DIETARY_SUPPLEMENT

Glizigen Placebo

The placebo of GLIZIGEN® product is presented in spray bottles and will be administered orally to swallow, away from meals 2 times a day.

Trial Locations (1)

10600

Gastroenterology Institute, Vedado

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT03584308 - Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal | Biotech Hunter | Biotech Hunter